Central Cervical Dissection of Lymphonodes in the Management of Differentiated Thyroid Carcinoma – Our Experience

Česká verzia

Authors: R. Králik; V. Straka; V. Marek; M. Sabol; P. Chválny; P. Mračna
Authors place of work: Klinika onkologickej chirurgie LF UKo, Onkologický ústav sv. Alžbety, Bratislava, Slovenská republika prednosta: doc. MUDr. Š. Durdík, Ph. D.
Published in the journal: Rozhl. Chir., 2008, roč. 87, č. 3, s. 149-153.
Category: Monothematic special - Original

Summary

Introduction:
Total thyroidectomy (TTE) with central compartment lymphonodes (LU) dissection remains a standard procedure in the treatment of differentiated thyroid carcinomas.

Methodology:
The retrospective study assessed a group of patients undergoing primary or secondary procedures in our clinic.

Patient group:
From 01. 01. 2005 to 31. 07. 2007, a total of 50 patients underwent primary procedures, TTE with dissection of central compartment lymphonodes was performed in 18 patients, 58 patients were reoperated for relapses of the disorder. In the primary procedures, the central compartment lymphonodes were affected with increased rate,proportionally to a T-stage of the disorder – 28 % (T1), 52 % (T2), 58 % (T3). Multifocal carcinoma was associated with a high risk, where metastatic lymphadenopathy occured in 53% of the cases. In the reoperated subjects, relapses of the disorder were recorded in 78% of the patients in their central compartment lymphonodes and their thyreoglobulin levels decreased. Out of 126 patients, paresis of the nervus laryngeus reccurens was recorded in 4 subjects (3.1 %) and postoperative hypoparathyreosis in 14 subjects (11 %).

Conclusion:
Dissection of lymphonodes is a standard part of the surgical management of differentiated carcinomas, providing local control of the disease. 78 % of the relapses were located within the central compartment. Risk and complication rates correspond to those reported in total thyroidectomy.

Key words:
differentiated thyroid carcinoma – surgical management – dissection of the central compartment lymphonodes

Zdroje

1. Buhr, H., Mann, B. Thyroidectomie und lymfadenectomie. Chirurg, 1999, 988–933.

2. Dralle, H., a kol. Chirurgie der Schilddrusenkarzinome. Onkologe, 2005, 11: 58–69.

3. Dvořák, J. Rakovina štítné žlázy. Praha: nakl. Libri, 1997.

4. Gimm, O., Dralle, H. Lymphadenektomie beim Schilddrusen- und Nebenschilddrusenkarzinom. Chirurg, 2007, 78: 182–193.

5. Králik R., a kol. Dokončenie totálnej tyreoidektómie pre diferencovaný karcinóm štítnej žľazy. Rozhl. Chir., 2007, 86: 366–369.

6. Pacini, F., Schlumberger2 M., (Coordinators), Dralle3, H., Elisei4, R., Wiersinga5, W. and the European Thyroid Cancer Taskforce§. 1Section of Endocrinology and Metabolism, University of Siena, Italy; 2Service de Medicine Nucleaire, Institut Gustave Roussy, Villejuif, France; 3Department of General, Visceral and Vascular Surgery, University of Halle, Germany; 4Department of Endocrinology, University of Pisa, Italy; 5Department of Endocrinology and Metabolism, University of Amsterdam, The Netherlands: European consensus for the management of patients with differentiated thyroid cancer of the follicular epithelium.* Eur. J. Endocrinol., 2006 Jun; 154(6): 787–803.

7. Rothmund, M., a kol. Endokrine Chirurgie. Springer-Verlag, Berlin Heidelberg, 2000, 594 s.

8. Schlumberger, M., Pacini, F. Thyroid Tumors. Edition Nucléon, Paris, 2003, 355 s.

9. Shindo, M., Wu, J., Park, E. The Impotance of Central Compartment Elective Lymph Node Excision in the Staging and Treatment of Papillary Thyroid Cancer. Arch. Otolaryngol. Head Neck Surg., 2006, 132: 650–654.

10. White, M., Gauger, P., Doherty, G. Central Lymph Node Dissection in Differentiated Thyroid Cancer. World J. Surg., 2007, 31: 895–904.